Point72 Asset Management
NUVB icon

Point72 Asset Management’s Nuvation Bio NUVB Stock Holding History

Point72 Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,588
Closed -$176K – 4268
2025
Q4 		$176K Buy
+19,588
New +$121K ﹤0.01% 3664
2025
Q1 		– Sell
-226,824
Closed -$603K – 2380
2024
Q4 		$603K Sell
226,824
-49,890
-18% -$128K ﹤0.01% 1618
2024
Q3 		$634K Buy
+276,714
New +$844K ﹤0.01% 1552
2023
Q2 		– Sell
-37,698
Closed -$62.6K – 2584
2023
Q1 		$62.6K Buy
+37,698
New +$76.4K ﹤0.01% 1741
2022
Q3 		– Sell
-288,300
Closed -$934K – 1641
2022
Q2 		$934K Buy
+288,300
New +$1.26M ﹤0.01% 1095
2021
Q4 		– Sell
-152,300
Closed -$1.51M – 1231
2021
Q3 		$1.51M Buy
+152,300
New +$1.38M 0.01% 812

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Point72 Asset Management's NUVB Position: Q1 2026 in Review

Point72 Asset Management sold out of Nuvation Bio (NUVB) in Q1 2026, closing a stake of 19,588 shares — an estimated $176K sold.

Point72 Asset Management first reported a position in NUVB in Q3 2021 and held it in 6 quarters. The position peaked at $1.51M in Q3 2021. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Point72 Asset Management reported no remaining Nuvation Bio position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 19,588 Nuvation Bio shares in Q1 2026, an estimated $176K.
  • Point72 Asset Management first reported a position in Nuvation Bio in Q3 2021 and held it in 6 quarters.
  • Point72 Asset Management's Nuvation Bio position peaked at $1.51M in Q3 2021.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.